Please login to the form below

Zentiva

This page shows the latest Zentiva news and features for those working in and with pharma, biotech and healthcare.

Sanofi warns of difficult few months as diabetes sales slump

said that the last few months have included the pipeline-building acquisitions of Bioverativ and Ablynx and the sale of its Zentiva generics business to a private equity group.

Latest news

Sanofi appoints ex-Roche Reed as new R&D head

Brandicourt has also demonstrated his commitment to pursuing the core pharma business at Sanofi by selling off its Zentiva generics business for 1.9bn ($2.4bn).
Sanofi sells European generics to Advent for $2.4bn

Sanofi has been looking to divest the Zentiva generics unit since 2016 as part of restructuring the business under chief executive Olivier Brandicourt, who said: “Transferring this business to Advent is ... Sanofi bought the foundations of its European
Ten new medicines recommended in Europe

Duloxetine Zentiva (duloxetine) - a copycat of Lilly's Cymbalta - for the treatment of major depressive disorder, diabetic peripheral neuropathic pain and generalised anxiety disorder, also saw a nod from the EMA.
Three cancer immunotherapies amongst new CHMP approvals

Finally, two generic medicines gained positive opinions: Bortezomib Accord (bortezomib) for the treatment of multiple myeloma and mantle cell lymphoma and Pregabalin Zentiva (pregabalin) for the treatment of epilepsy and generalised
Orphan drugs in latest CHMP recommendations

Completing the positive opinions were two new informed consent applications: Sevelamer carbonate Zentiva (sevelamer) from Genzyme for the control of hyperphosphataemia in adults receiving haemodialysis or peritoneal dialysis and Rasagiline

More from news
Approximately 1 fully matching, plus 16 partially matching documents found.

Latest appointments

Karim Husny moves from Omega Pharma to Alliance Pharmaceuticals

He brings experience in over the counter and consumer healthcare having worked at several European pharmaceutical firms, including Laboratoire de la Mer, Pfizer and Sanofi's Zentiva business.
Watson selects global generics management team

Ramneborn has more than 20 years' experience in the pharmaceutical industry and joined Actavis from Zentiva, where he was vice president and a member of the board of directors since 2003.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Account Director, Medical Education: Salary TBC

Senior Medical Writer, MedComms Agency: Salary TBC

Account Director: £Competitive Salary

Account Director, Healthcare Communications: Salary TBC

Senior External Communications Lead: £Competitive Salary

Account Manager (PR): Great Benefits

Account director: Competitive salary and bonus scheme

Group Director of Medical Affairs and Scientific Strategy, Medic...: Substantial six figure package

Digital Associate Director - Medcomms: £65000 - £80000 per annum

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Brand Manager - Medium Global Pharma Company: £Competitive Financial Package

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Scientific Director: £60000 - £85000 per annum, Benefits: Bonus, pension, subsidised gym and much more

Senior Medical Writer or Lead Medical Writer: £Competitive Salary

Experienced medical editor: Competitive salary and bonus scheme

Publications director: Competitive salary and bonus scheme

Account Manager: £Competitive Salary

Subscribe to our email news alerts

PMHub

Add my company

Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Novo Nordisk awakens its ‘Sleeping Beauty’: Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?: Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019: OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...